425 related articles for article (PubMed ID: 26143738)
1. High reactive oxygen species in fibrotic and nonfibrotic skin of patients with diffuse cutaneous systemic sclerosis.
Bourji K; Meyer A; Chatelus E; Pincemail J; Pigatto E; Defraigne JO; Singh F; Charlier C; Geny B; Gottenberg JE; Punzi L; Cozzi F; Sibilia J
Free Radic Biol Med; 2015 Oct; 87():282-9. PubMed ID: 26143738
[TBL] [Abstract][Full Text] [Related]
2. Earliest Phase of Systemic Sclerosis Typified by Increased Levels of Inflammatory Proteins in the Serum.
Cossu M; van Bon L; Preti C; Rossato M; Beretta L; Radstake TRDJ
Arthritis Rheumatol; 2017 Dec; 69(12):2359-2369. PubMed ID: 28859262
[TBL] [Abstract][Full Text] [Related]
3. The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations.
Yalçinkaya Y; Çinar S; Artim-Esen B; Kamali S; Öcal L; Deniz G; Inanç M
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):110-114. PubMed ID: 27749243
[TBL] [Abstract][Full Text] [Related]
4. Correlation of serum collagen I carboxyterminal telopeptide concentrations with cutaneous and pulmonary involvement in systemic sclerosis.
Allanore Y; Borderie D; Lemaréchal H; Cherruau B; Ekindjian OG; Kahan A
J Rheumatol; 2003 Jan; 30(1):68-73. PubMed ID: 12508392
[TBL] [Abstract][Full Text] [Related]
5. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
[TBL] [Abstract][Full Text] [Related]
6. Increased serum pentraxin 3 in patients with systemic sclerosis.
Iwata Y; Yoshizaki A; Ogawa F; Komura K; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Takehara K; Sato S
J Rheumatol; 2009 May; 36(5):976-83. PubMed ID: 19273457
[TBL] [Abstract][Full Text] [Related]
7. A possible contribution of visfatin to the resolution of skin sclerosis in patients with diffuse cutaneous systemic sclerosis via a direct anti-fibrotic effect on dermal fibroblasts and Th1 polarization of the immune response.
Masui Y; Asano Y; Shibata S; Noda S; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Yanaba K; Tada Y; Sugaya M; Sato S; Kadono T
Rheumatology (Oxford); 2013 Jul; 52(7):1239-44. PubMed ID: 23443327
[TBL] [Abstract][Full Text] [Related]
8. Skin involvement in scleroderma--where histological and clinical scores meet.
Verrecchia F; Laboureau J; Verola O; Roos N; Porcher R; Bruneval P; Ertault M; Tiev K; Michel L; Mauviel A; Farge D
Rheumatology (Oxford); 2007 May; 46(5):833-41. PubMed ID: 17255134
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of angiogenic homeostasis in systemic sclerosis.
Farouk HM; Hamza SH; El Bakry SA; Youssef SS; Aly IM; Moustafa AA; Assaf NY; El Dakrony AH
Int J Rheum Dis; 2013 Aug; 16(4):448-54. PubMed ID: 23992267
[TBL] [Abstract][Full Text] [Related]
10. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
Manetti M; Guiducci S; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486
[TBL] [Abstract][Full Text] [Related]
11. Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse.
Servettaz A; Goulvestre C; Kavian N; Nicco C; Guilpain P; Chéreau C; Vuiblet V; Guillevin L; Mouthon L; Weill B; Batteux F
J Immunol; 2009 May; 182(9):5855-64. PubMed ID: 19380834
[TBL] [Abstract][Full Text] [Related]
12. Perivascular Cells in Diffuse Cutaneous Systemic Sclerosis Overexpress Activated ADAM12 and Are Involved in Myofibroblast Transdifferentiation and Development of Fibrosis.
Cipriani P; Di Benedetto P; Ruscitti P; Liakouli V; Berardicurti O; Carubbi F; Ciccia F; Guggino G; Zazzeroni F; Alesse E; Triolo G; Giacomelli R
J Rheumatol; 2016 Jul; 43(7):1340-9. PubMed ID: 27252423
[TBL] [Abstract][Full Text] [Related]
13. CD16-positive circulating monocytes and fibrotic manifestations of systemic sclerosis.
Lescoat A; Lecureur V; Roussel M; Sunnaram BL; Ballerie A; Coiffier G; Jouneau S; Fardel O; Fest T; Jégo P
Clin Rheumatol; 2017 Jul; 36(7):1649-1654. PubMed ID: 28293753
[TBL] [Abstract][Full Text] [Related]
14. Skin fibrosis correlates with circulating thyrotropin levels in systemic sclerosis: translational association with Hashimoto's thyroiditis.
Bagnato GL; Roberts WN; Fiorenza A; Arcuri C; Certo R; Trimarchi F; Ruggeri RM; Bagnato GF
Endocrine; 2016 Feb; 51(2):291-7. PubMed ID: 25994300
[TBL] [Abstract][Full Text] [Related]
15. A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels.
Polisson RP; Gilkeson GS; Pyun EH; Pisetsky DS; Smith EA; Simon LS
J Rheumatol; 1996 Apr; 23(4):654-8. PubMed ID: 8730122
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of galectin-3: possible association with fibrosis, aberrant angiogenesis, and immune activation in patients with systemic sclerosis.
Taniguchi T; Asano Y; Akamata K; Noda S; Masui Y; Yamada D; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
J Rheumatol; 2012 Mar; 39(3):539-44. PubMed ID: 22247367
[TBL] [Abstract][Full Text] [Related]
17. Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis.
Yamaguchi Y; Ono J; Masuoka M; Ohta S; Izuhara K; Ikezawa Z; Aihara M; Takahashi K
Br J Dermatol; 2013 Apr; 168(4):717-25. PubMed ID: 23110679
[TBL] [Abstract][Full Text] [Related]
18. Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis.
Wohlfahrt T; Usherenko S; Englbrecht M; Dees C; Weber S; Beyer C; Gelse K; Distler O; Schett G; Distler JH; Ramming A
Ann Rheum Dis; 2016 Mar; 75(3):623-6. PubMed ID: 26338035
[TBL] [Abstract][Full Text] [Related]
19. In vivo reflectance confocal microscopy features of cutaneous microcirculation and epidermal and dermal changes in diffuse systemic sclerosis and correlation with histological and videocapillaroscopic findings.
Venturini M; Arisi M; Zanca A; Cavazzana I; Gonzàlez S; Franceschini F; Calzavara-Pinton P
Eur J Dermatol; 2014; 24(3):349-55. PubMed ID: 24721824
[TBL] [Abstract][Full Text] [Related]
20. Aortic stiffness in systemic sclerosis is increased independently of the extent of skin involvement.
Moyssakis I; Gialafos E; Vassiliou V; Taktikou E; Katsiari C; Papadopoulos DP; Sfikakis PP
Rheumatology (Oxford); 2005 Feb; 44(2):251-4. PubMed ID: 15546962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
